← Evidence map

ReviewFrontiers in immunology2025

Development and landscape of maintenance therapy after first-line treatment of advanced or metastatic urothelial carcinoma.

Zengguang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40821840